Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929

202425 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Thoracic Oncology

Volume 20, Issue 3, pp. 383-394

Field-Weighted Citation Impact: 7.00